blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2387424

EP2387424 - METHOD AND MEMBRANE FOR TISSUE REGENERATION [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  17.11.2017
Database last updated on 05.10.2024
FormerExamination is in progress
Status updated on  17.01.2017
Most recent event   Tooltip17.11.2017Application deemed to be withdrawnpublished on 20.12.2017  [2017/51]
Applicant(s)For all designated states
Geistlich Pharma AG
Bahnhofstrasse 40
6110 Wolhusen / CH
[2011/47]
Inventor(s)01 / GEISTLICH, Peter
Kehrsitenstrasse 19
CH-6362 Stansstad / CH
02 / SCHLOESSER, Lothar
Von-der-Au-Strasse 27
64297 Darmstadt / DE
 [2011/47]
Representative(s)Matthews, Derek Peter
Dehns
St Bride's House
10 Salisbury Square
London EC4Y 8JD / GB
[N/P]
Former [2011/47]Matthews, Derek Peter
Dehns St Bride's House 10 Salisbury Square
GB-London EC4Y 8JD / GB
Application number, filing date10712767.218.01.2010
WO2010IB00200
Priority number, dateUS20090145334P16.01.2009         Original published format: US 145334 P
[2011/47]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2010082138
Date:22.07.2010
Language:EN
[2010/29]
Type: A2 Application without search report 
No.:EP2387424
Date:23.11.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 22.07.2010 takes the place of the publication of the European patent application.
[2011/47]
Search report(s)International search report - published on:EP24.02.2011
ClassificationIPC:A61L31/04, A61L31/14, A61L27/24, A61L27/54, A61L27/56
[2011/47]
CPC:
A61L31/044 (EP,US); A61L31/146 (EP,US); A61L31/148 (EP,US);
A61P17/00 (EP); A61P17/02 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR 
TitleGerman:VERFAHREN UND MEMBRAN ZUR GEWEBEREGENERATION[2011/47]
English:METHOD AND MEMBRANE FOR TISSUE REGENERATION[2011/47]
French:PROCÉDÉ ET MEMBRANE POUR RÉGÉNÉRATION DE TISSUS[2011/47]
Entry into regional phase16.08.2011National basic fee paid 
16.08.2011Designation fee(s) paid 
16.08.2011Examination fee paid 
Examination procedure14.03.2011Request for preliminary examination filed
International Preliminary Examining Authority: EP
16.08.2011Examination requested  [2011/47]
22.03.2012Amendment by applicant (claims and/or description)
07.08.2012Despatch of a communication from the examining division (Time limit: M06)
15.02.2013Reply to a communication from the examining division
29.01.2015Despatch of a communication from the examining division (Time limit: M06)
10.08.2015Reply to a communication from the examining division
05.01.2017Despatch of a communication from the examining division (Time limit: M06)
18.07.2017Application deemed to be withdrawn, date of legal effect  [2017/51]
11.08.2017Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2017/51]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  07.08.2012
Fees paidRenewal fee
25.01.2012Renewal fee patent year 03
29.01.2013Renewal fee patent year 04
30.01.2014Renewal fee patent year 05
23.01.2015Renewal fee patent year 06
27.01.2016Renewal fee patent year 07
20.01.2017Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XI]US2008107710  (GEISTLICH PETER [CH], et al) [X] 20-23,27-33 * paragraphs [0002] , [0015] , [0043] , [0051] , [0055] , [0058] , [0074] * * claims 1-8 * [I] 24-26,34-41;
 [X]EP1252903  (GEISTLICH SOEHNE AG [CH]) [X] 20,21,24,25,27-33 * paragraphs [0015] - [0018] * * claims 1-4,6. 11,12 *;
 [A]  - JIN QIMING ET AL, "Nanofibrous Scaffolds Incorporating PDGF-BB Microspheres Induce Chemokine Expression and Tissue Neogenesis In Vivo", PLOS ONE, (20080305), vol. 3, no. 3, doi:DOI:10.1371/JOURNAL.PONE.0001729, ISSN 1932-6203, pages 1 - 9, XP002609816 [A] 20-41 * abstract * * page 5, column 2, paragraph 2 - page 7, column 2, paragraph 2 *

DOI:   http://dx.doi.org/10.1371/journal.pone.0001729
ExaminationUS2007031388
 US5837278
by applicantUS6713085
 US5837278
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.